NCT07149415View on ClinicalTrials.gov

A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 2, 2025

Primary Completion Date

October 16, 2025

Study Completion Date

October 16, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

Omaveloxolone

Oral capsules

DRUG

Omeprazole

Oral tablet

Trial Locations (1)

78744

Austin Clinical Research Unit, Austin

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT07149415 - A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55 | Biotech Hunter | Biotech Hunter